Aug 2026· Trends in Biotechnology· 0 citations· 9 references
Medicine
TL;DR
How this framework may apply to oriGen, why the nature of the material transferred is legally decisive, and publicly verifiable clarification of the applicable permit and registry requirements is essential for regulatory accountability, participant trust, lawful national stewardship, and responsible, equitable international genomic collaboration are clarified.
Abstract
Mexico's General Health Law regulates certain transfers abroad of human tissues used in population genomic studies. We clarify how this framework may apply to oriGen, why the nature of the material transferred is legally decisive, and why publicly verifiable clarification of the applicable permit and registry requirements is essential for regulatory accountability, participant trust, lawful national stewardship, and responsible, equitable international genomic collaboration.
This article is devoted to the legal regulation of the use of genomic editing technology in individual states. In general, it can
be stated that in most legal systems there are restrictions on genomic editing in relation to hereditary genes, however, in rare cases
exceptions are allowed, which must be recognized as jus...
Anastasia E. Kraynyukova· Civil society in Russia and...· 0 citations
The current legal framework is analyzed, the existing need for legislative action is identified, the existing need for legislative action is identified and a practice-oriented regulatory proposal is developed.
A narrative review examines biobanking and genomic research infrastructure in sub-Saharan Africa and its implications for precision oncology, highlighting that locally governed, sustainable biobanks and equitable international partnerships are fundamental prerequisites for Precision Oncology Without Borders.
This paper examines Indonesia’s legal framework for cross-border transfer of genomic data and evaluates how it balances the rights of data subjects, state sovereignty, and national security. Using a normative juridical method supported by comparative analysis, it reviews the Personal Data Protection Law 2022 and the He...
Tri Andika, Zainul Daulay, Ferdi et al.· Journal of Data Protection &...· 0 citations
Genomic datasets exist in Canada; however, many are inaccessible because they are held by individual researchers on institutional servers or by third-party sequencing companies abroad.
As a result, the genomic evidence needed to evaluate new therapies is often difficult to find.
Genome Canada is working to improve da...
Naveed Aziz, Chief Data Officer, Genome Canada· Canadian Journal of Health T...· 0 citations
The career journey from molecular cancer biology through GMP manufacturing and regulatory science into health policy, the evolving regulatory landscape for cell and gene therapies in Singapore and the Asia‑Pacific region, the role of regulatory reliance frameworks in broadening equitable patient access, and the transfo...
Eddie Tan Han Pin· Cell and Gene Therapy Insigh...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
